Quality assurance in head and neck cancer surgery: where are we, and where are we going?

被引：6

作者：

Simon, Christian ^{[1
]}

Dietz, Andreas ^{[2
]}

Leemans, C. Rene ^{[3
]}

机构：

[1] Univ Lausanne UNIL, CHUV, Serv Otorhinolaryngol Chirurg Cervicofaciale, Rue Bugnon, Lausanne, Switzerland

[2] Univ Leipzig, Dept Otolaryngol Head & Neck Surg, Liebigstr, Leipzig, Germany

[3] Vrije Univ Amsterdam, Med Ctr, Canc Ctr Amsterdam, Dept Otolaryngol Head & Neck Surg, Boelelaan, Amsterdam, Netherlands

来源：

CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY | 2019年 / 27卷 / 02期

关键词：

clinical trials; The European Organization for Research and Treatment of Cancer; head and neck cancer; quality assurance; AMERICAN-COLLEGE; SURGICAL CARE; MAJOR HEAD; IMPROVEMENT PROGRAM; RISK CALCULATOR; COMPLICATIONS; METRICS;

D O I：

10.1097/MOO.0000000000000519

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

Purpose of review The scope of this review is to summarize current efforts in quality assurance for head and neck cancer surgery. National and international initiatives are summarized and progress in terms of identification of process indicators and outcome indicators delineated. Recent findings Massive efforts have been made in order to improve quality of head and neck cancer surgery. New guidelines for quality assurance of head and neck cancer surgery in clinical trials have recently been proposed by EORTC. Summary Quality assurance programs can be tested within the clearly defined environment of prospective clinical trials. If positive, such programs could be rolled out within national healthcare systems, if feasible. Testing quality programs in clinical trials could be a versatile tool to help head neck cancer patients benefit from such initiatives on a global level.

引用

页码：151 / 156

页数：6

共 50 条

[21] Where we are, where we are going
Bermejo-Vicedo, Teresa
Queralt-Gorgas, Maria
[J]. FARMACIA HOSPITALARIA, 2020, 44 (02) : 37 - 38
[22] Where we are, where we are going ...
Grossman, G. D.
Lobon-Cervia, J.
[J]. ECOLOGY OF FRESHWATER FISH, 2007, 16 (04) : 465 - 467
[23] Where are we? Where are we going?
Stephanie J. Bird
[J]. Science and Engineering Ethics, 2001, 7 : 163 - 164
[24] Where are we? Where are we going?
Bird, SJ
[J]. SCIENCE AND ENGINEERING ETHICS, 2001, 7 (02) : 163 - 164
[25] Where we are and where we are going
FNACE MP, France
[J]. Mater Perform, 1 (14):
[26] Where We Were, Where We Are, Where We Are Going
Epstein, Burton S.
[J]. ANESTHESIA AND ANALGESIA, 2011, 113 (03): : 480 - 483
[27] Biomarkers in Breast Cancer: Where Are We and Where Are We Going?
Duffy, Michael J.
Walsh, Siun
McDermott, Enda W.
Crown, John
[J]. ADVANCES IN CLINICAL CHEMISTRY, VOL 71, 2015, 71 : 1 - 23
[28] Prostate cancer immunotherapy: where are we and where are we going?
De Velasco, Marco A.
Uemura, Hirotsugu
[J]. CURRENT OPINION IN UROLOGY, 2018, 28 (01) : 15 - 24
[29] Diet and cancer prevention: Where we are, where we are going
Gonzalez, Carlos A.
Riboli, Elio
[J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2006, 56 (02): : 225 - 231
[30] Spine Surgery: Where Have We Been? And Where Are We Going?
Rogerson, Ashley
[J]. OPERATIVE TECHNIQUES IN ORTHOPAEDICS, 2023, 33 (04)

← 1 2 3 4 5 →